πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to BioVie Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

ABVC BioPharma, Inc.

ABVC BioPharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1702, ABV-1601, ABV-1701 Vitargus

ABVC Bio Pharma, Inc., based in Fremont, California, is a clinical stage biopharmaceutical company developing drugs and medical devices to address unmet medical needs in the United States. The company is involved in developing therapies for conditions such as cancer, major depressive disorders, and attention deficit hyperactivity disorder.

Tags: biopharmaceutical, clinical trials, drug development, medical devices, mental health, oncology

Symbol: ABVC

Recent Price: $0.59

Industry: Biotechnology

CEO: Dr. Uttam Yashwant Patil Ph.D.

Sector: Healthcare

Employees: 16

Address: 44370 Old Warm Springs Boulevard, Fremont, CA 94538

Phone: 510 668 0881

Last updated: 2024-12-31

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logo
Market Cap: Medium
Employees: Lowest

ANAVEX 2-73

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.

Tags: Alzheimer's, CNS diseases, Parkinson's, Rett syndrome, biopharmaceutical, clinical trials, neurodegenerative diseases

Symbol: AVXL

Recent Price: $11.04

Industry: Biotechnology

CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.

Sector: Healthcare

Employees: 40

Address: 51 West 52nd Street, New York, NY 10019

Phone: 844 689 3939

Last updated: 2024-12-31

BioVie Inc.

BioVie Inc. logo
Market Cap: Lowest
Employees: Lowest

BIV201, NE3107

Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.

Tags: Alzheimer's, Biotechnology, Clinical Trials, Drug Development, Liver Cirrhosis, Parkinson's, Pharmaceutical

Symbol: BIVI

Recent Price: $2.09

Industry: Biotechnology

CEO: Mr. Cuong Viet Do M.B.A.

Sector: Healthcare

Employees: 14

Address: 680 West Nye Lane, Carson City, NV 89703

Phone: 775 888 3162

Last updated: 2024-12-31

Belite Bio, Inc

Belite Bio, Inc logo
Market Cap: High
Employees: Lowest

LBS-008

Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.

Tags: Stargardt diseases, biopharmaceutical, clinical-stage, drug development, liver disease, macular degeneration, phase 3, therapeutics

Symbol: BLTE

Recent Price: $61.97

Industry: Biotechnology

CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.

Sector: Healthcare

Employees: 20

Address: 5820 Oberlin Drive, San Diego, CA 92121

Phone: 858-246-6240

Last updated: 2024-12-31

bluebird bio, Inc.

bluebird bio, Inc. logo
Market Cap: Low
Employees: Medium

betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel

bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.

Tags: betibeglogene autotemcel, biotechnology, elivaldogene autotemcel, gene therapy, genetic diseases, lovotibeglogene autotemcel

Symbol: BLUE

Recent Price: $7.86

Industry: Biotechnology

CEO: Mr. Andrew Obenshain

Sector: Healthcare

Employees: 375

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Leadership

  • Sarah Alspach, Senior Vice President, External Affairs
  • Rich Colvin, MD, PhD, Chief Medical Officer
  • Kasra Kasraian, Senior Vice President, Technical Development and Operations
  • Tom Klima, Chief Commercial & Operating Officer
  • Andrew Obenshain, Chief Executive Officer
  • Scott Shoemaker, Senior Vice President, Quality
  • James Sterling, Chief Financial Officer
  • Joe Vittiglio, Chief Business and Legal Officer
  • Andrea Walton, Chief People Officer
  • Leslie Wilder, Vice President, Head of Regulatory Science
  • Mark Vachon, Chairman; Formerly of GE
  • John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
  • Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
  • Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
  • Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
  • Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
  • Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
  • Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Cue Biopharma, Inc.

Cue Biopharma, Inc. logo
Market Cap: Low
Employees: Lowest

CUE-101

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing biologic drugs to modulate the human immune system for treating cancers, chronic infectious diseases, and autoimmune disorders.

Tags: autoimmune disorders, biopharmaceutical, cancer, chronic diseases, immune system

Symbol: CUE

Recent Price: $1.02

Industry: Biotechnology

CEO: Mr. Daniel R. Passeri J.D., M.Sc.

Sector: Healthcare

Employees: 53

Address: 21 Erie Street, Cambridge, MA 02139

Phone: 617 949 2680

Leadership

  • Dan Passeri, Chief Executive Officer
  • Anish Suri, President and Chief Scientific Officer
  • Lucinda Warren, Chief Business Officer
  • Matteo Levisetti, Chief Medical Officer
  • Kerri-Ann Millar, Chief Financial Officer
  • Colin Sandercock, Senior Vice President and General Counsel
  • Frank Morich, M.D., Ph.D., Chairman of the Board
  • Dan Passeri, M.Sc., J.D., Chief Executive Officer
  • Peter Kiener, D.Phil.,
  • Fred Driscoll,
  • Patrick Verheyen,
  • Pamela D. Garzone, Ph.D.,

Last updated: 2024-12-31

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. logo
Market Cap: High
Employees: Medium

lifileucel

Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products to utilize the immune system in eradicating cancer cells, with several ongoing phase 2 clinical studies.

Tags: biotechnology, cancer immunotherapy, cancer treatment, clinical-stage, lifileucel

Symbol: IOVA

Recent Price: $7.17

Industry: Biotechnology

CEO: Dr. Frederick G. Vogt Esq., J.D., Ph.D.

Sector: Healthcare

Employees: 557

Address: 825 Industrial Road, San Carlos, CA 94070

Phone: 650 260 7120

Last updated: 2024-12-31

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANA001

A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.

Tags: biotechnology, cardiometabolic diseases, clinical trials, infectious diseases, neurodegenerative diseases

Symbol: NRBO

Recent Price: $2.36

Industry: Biotechnology

CEO: Mr. Hyung-Heon Kim

Sector: Healthcare

Employees: 8

Address: 200 Berkeley Street, Boston, MA 02116

Phone: 857 702 9600

Last updated: 2024-12-31

Palisade Bio, Inc.

Palisade Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

LB1148

Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.

Tags: LB1148, biopharmaceutical, clinical-stage, gastrointestinal health, mucosal barrier, oral therapies

Symbol: PALI

Recent Price: $1.70

Industry: Biotechnology

CEO: Mr. J. D. Finley

Sector: Healthcare

Employees: 9

Address: 5800 Armada Drive, Carlsbad, CA 92008

Phone: 858 704 4900

Last updated: 2024-12-31

Rallybio Corporation

Rallybio Corporation logo
Market Cap: Lowest
Employees: Lowest

RLYB212

Rallybio Corporation is a clinical-stage biotechnology company focused on discovering, developing, manufacturing, and delivering therapies for severe and rare diseases, with a lead product candidate RLYB212 in clinical trials.

Tags: biotechnology, clinical trials, monoclonal antibodies, rare diseases, therapeutics

Symbol: RLYB

Recent Price: $0.93

Industry: Biotechnology

CEO: Dr. Stephen Uden M.B, M.D.

Sector: Healthcare

Employees: 25

Address: 234 Church Street, New Haven, CT 06510

Phone: 203 859 3820

Last updated: 2024-12-31

2seventy bio, Inc.

2seventy bio, Inc. logo
Market Cap: Low
Employees: Low

idecabtagene vicleucel

2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.

Tags: biotechnology, cancer treatment, cell therapy, gene therapy, multiple myeloma

Symbol: TSVT

Recent Price: $2.89

Industry: Biotechnology

CEO: Mr. William D. Baird III, M.B.A.

Sector: Healthcare

Employees: 274

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Last updated: 2024-12-31

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111

Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.

Tags: COVID-19, HIV, biotechnology, hepatitis B, immunology, infectious diseases, influenza, therapeutics

Symbol: VIR

Recent Price: $7.33

Industry: Biotechnology

CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

Sector: Healthcare

Employees: 587

Address: 499 Illinois Street, San Francisco, CA 94158

Phone: 415 906 4324

Leadership

  • Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
  • Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
  • Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
  • Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
  • Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
  • Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
  • Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
  • Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
  • Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
  • Arran Attridge, Senior Vice President Corporate Communications
  • Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
  • Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow

Last updated: 2024-12-31

ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc. logo
Market Cap: Lowest
Employees: Lowest

natural bioactive ingredients

ZIVO Bioscience, Inc. is a research and development company specializing in licensing and selling natural bioactive ingredients derived from proprietary algae cultures, serving the biotech and agtech sectors with intellectual property in human and animal health applications.

Tags: agtech, algae cultures, animal health, biotech, human health, intellectual property, natural bioactive ingredients

Symbol: ZIVO

Recent Price: $20.89

Industry: Biotechnology

CEO: Mr. John B. Payne

Sector: Healthcare

Employees: 8

Address: 21 East Long Lake Road, Bloomfield Hills, MI 48304

Phone: 248 452 9866

Leadership

  • John B. Payne, President / Chief Executive Officer / Chairman of the Board
  • Keith Marchiando, Chief Financial Officer
  • William P. Pfund, Vice-President, Research & Development
  • Dr. Amy Steffek, Director, Research & Development
  • Dr. Harlan L. Miller III, Vice-President of Technology and Global Supply
  • Dr. Laura Belicka, Senior Scientist
  • Amy Elizabeth Steffek, Director of Research & Development
  • Alison A. Cornell, Executive Vice President & Chief Financial Officer
  • Christopher Maggiore, Director
  • Nola E. Masterson, Director
  • Laith Yaldoo, Director

Last updated: 2024-12-31

Annovis Bio, Inc.

Annovis Bio, Inc. logo
Market Cap: Low
Employees: Lowest

Buntanetap

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound, Buntanetap, is in clinical trials for various neurodegenerative disorders.

Tags: Alzheimer's disease, Parkinson's disease, clinical trials, drug development, neurodegeneration

Symbol: ANVS

Recent Price: $5.08

Industry: Biotechnology

CEO: Dr. Maria L. Maccecchini Ph.D.

Sector: Healthcare

Employees: 6

Address: 1055 Westlakes Drive, Berwyn, PA 19312

Phone: 610 727 3913

Last updated: 2024-12-31

Nuvation Bio Inc.

Nuvation Bio Inc. logo
Market Cap: Medium
Employees: Low

NUV-422

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focusing on the development of therapeutic candidates for oncology, such as NUV-422, a small molecule inhibitor targeting cyclin-dependent kinases, among other innovative treatments.

Tags: NUV-422, biopharmaceutical, oncology, therapeutic development

Symbol: NUVB

Recent Price: $2.62

Industry: Biotechnology

CEO: Dr. David T. Hung M.D.

Sector: Healthcare

Employees: 51

Address: 1500 Broadway, New York, NY 10036

Phone: 332 208 6102

Last updated: 2024-12-31

Theriva Biologics, Inc.

Theriva Biologics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SYN-004, SYN-020, VCN-01

Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.

Tags: biologics, biopharmaceutical, clinical-stage, disease treatment, microbiome, therapeutics

Symbol: TOVX

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Steven A. Shallcross CPA

Sector: Healthcare

Employees: 22

Address: 9605 Medical Center Drive, Rockville, MD 20850

Phone: 301 417 4364

Last updated: 2024-12-31

BioLife Solutions, Inc.

BioLife Solutions, Inc. logo
Market Cap: Medium
Employees: Medium

bioproduction tools and services

Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.

Tags: biological storage, biologics, biopreservation, cell therapy, cryogenic equipment, gene therapy, pharmaceuticals, temperature-sensitive storage

Symbol: BLFS

Recent Price: $26.27

Industry: Medical - Instruments & Supplies

CEO: Mr. Roderick de Greef

Sector: Healthcare

Employees: 409

Address: 3303 Monte Villa Parkway, Bothell, WA 98021

Phone: 425 402 1400

Leadership

  • Rod de Greef, Chairman & Chief Executive Officer
  • Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
  • Karen Foster, Chief Quality and Operations Officer
  • Troy Wichterman, Chief Financial Officer
  • Todd Berard, Chief Marketing Officer
  • Garrie Richardson, Chief Revenue Officer
  • Sarah Aebersold, Chief Human Resources Officer
  • Mike Pallotta, Global VP, Hardware and Electrical Engineering
  • Brett Stucker, VP of Cybersecurity and Information Security Officer
  • Amy DuRoss,
  • Rachel Ellingson,
  • Joydeep Goswami, MBA, Ph.D.,
  • Tim Moore,
  • Joseph Schick, Chairman – Audit Committee
  • Andrew Hinson,
  • Anthony Davies, Ph.D.,
  • Colleen Delaney, M.D., M.Sc.,
  • Dayong Gao, Ph.D.,
  • Erik Woods, Ph.D., HCLD(ABB),
  • Jon Rowley, Ph.D.,
  • John McMannis, Ph.D.,
  • Jerry E. Cooley, M.D.,
  • Jason Acker, MBA, Ph.D.,
  • Lizabeth Cardwell, MT (ASCP), MBA, RAC,
  • Scott R. Burger, M.D.,
  • Shelly Heimfeld, Ph.D.,

Last updated: 2024-12-31

Denali Therapeutics Inc.

Denali Therapeutics Inc. logo
Market Cap: High
Employees: Medium

BIIB122/DNL151

Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutic candidates for neurodegenerative diseases. Its pipeline includes treatments for Parkinson's disease, hunter syndrome, ALS, multiple sclerosis, and Alzheimer's disease. It collaborates with companies such as Takeda Pharmaceutical Company and Genentech, Inc.

Tags: ALS, Alzheimer's disease, Parkinson's disease, biopharmaceutical, hunter syndrome, multiple sclerosis, neurodegenerative diseases

Symbol: DNLI

Recent Price: $20.24

Industry: Biotechnology

CEO: Dr. Ryan J. Watts Ph.D.

Sector: Healthcare

Employees: 364

Address: 161 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 866 8548

Last updated: 2024-12-31

IN8bio, Inc.

IN8bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

INB-200, INB-100, INB-400, INB-300

IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.

Tags: biopharmaceutical, biotechnology, cancer treatment, clinical trials, gamma-delta T cell therapies

Symbol: INAB

Recent Price: $0.27

Industry: Biotechnology

CEO: Mr. Tai-Wei Ho

Sector: Healthcare

Employees: 39

Address: 350 5th Avenue, New York, NY 10118

Phone: 646 600 6438

Last updated: 2024-12-31